Effect of topical imiquimod as primary treatment for lentigo maligna - the LIMIT-1 study

UK Dermatology Clinical Trials Network and the LIMIT-1 Collaborative Group, The NCRI Skin Cancer Clinical Studies Group

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
277 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Effect of topical imiquimod as primary treatment for lentigo maligna - the LIMIT-1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences